Medical cannabis in the UK: From principle to practice
Authors: Anne Katrin Schlag, David S Baldwin, Michael Barnes, Steve Bazire, Rachel Coathup, H Valerie Curran, Rupert McShane, Lawrence D...
top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Professor David Nutt
Apr 28, 20204 min read
When we waken from the COVID nightmare – what then?
For almost all of us, the current COVID-19 pandemic represents the first time we have been confronted with a personal and proximate...
Natasha L Mason, Patrick C Dolder and more
Jan 30, 20202 min read
Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts
Authors: Natasha L Mason, Patrick C Dolder, Kim PC Kuypers Published: January 30, 2020 Background It has been suggested that the outcome...
Jacob S Aday, Emily K Bloesch and more
Sep 3, 20191 min read
2018: A watershed year for psychedelic science
Authors: Jacob S Aday, Christopher C Davoli, Emily K Bloesch Published: September 3, 2019 While interest in the study of psychedelic...
Drug Science
Aug 27, 20192 min read
NICE on cannabidiol for childhood epilepsy
At the end of last week, NICE released their initial appraisal on cannabidiol in the form of Epidiolex for childhood epilepsy. As...
Ben Sessa, Chloe Sakal and more
Jul 22, 20192 min read
First safety study of MDMA-assisted psychotherapy in patients with alcohol use disorder
Authors: Ben Sessa, Chloe Sakal, Steve O’Brien and David Nutt Published: July 15, 2019 Read the full paper here (open access) We present...
Drug Science
May 16, 20193 min read
Drug Science launches Working Group on Medical Cannabis
Download the press release here The UK’s leading independent scientific body on drugs Launched the Drug Science Medical Cannabis Working...
Rudi Fortson QC
Sep 11, 20182 min read
ACMD advice on cannabis-derived medicinal products
On 11 September 2018, the ACMD published its Advice to the Home Secretary and to the Secretary of State for Health and Social Care. It...
Drug Science
Apr 11, 20181 min read
The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)
3,4-Methylenedioxymethamphetamine (MDMA), also known as ecstasy, was first synthesized in 1912 but first reached widespread popularity as...
Drug Science
Jul 26, 20171 min read
Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy
The potential of psychedelic drugs in the treatment of mental health problems is increasingly being recognized. However, relatively little t
Drug Science
Dec 10, 20164 min read
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future
This special issue of the Journal of Psychopharmacology contains two landmark studies – the most rigorous controlled trials to date using...
Drug Science
Apr 3, 20163 min read
Cannabis Review for the attention of the WHO
Read the full report The scheduling under the Single Convention on Narcotic Drugs assumes a scientific justification. However, cannabis...
Polly Taylor, Professor David Nutt and more
Mar 3, 20161 min read
Ketamine as an essential medicine
Authors: Polly Taylor, David Nutt, Val Curran, Rudi Fortson, and Graeme Henderson Published: March 11, 2016 A letter to The Lancet...
Drug Science
Mar 24, 20151 min read
Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary
Underground psychedelic-assisted psychotherapy has persisted in Europe despite the banning of the substances LSD and MDMA in the 1960s...
Drug Science
Feb 10, 20153 min read
The UK needs common sense about ketamine
A version of this post was published in The Guardian Ketamine is a unique anaesthetic and analgesic that has unfortunately become a...
bottom of page